Quentis Therapeutics

Biotechnology, Health Care, Therapeutics
Founded in 2016-01-01
New York, New York, United States
http://www.quentistx.com/
For Profit

About Quentis Therapeutics

Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to target ER stress pathways and awaken the immune system's ability to fight cancer, enabling patients to get access to new treatments for cancer.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 10 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 49000000 USD
  • Last Funding: 1000000 USD (Grant)
  • Funding Status: Early Stage Venture

Technology Stack

Quentis Therapeutics actively uses 10 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Therapeutics

Headquarters: New York, New York, United States